Device
CEFALY
CEFALY is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Validation of Therapeutic Effects of Cefaly on Insomnia
NCT04838067
completednot_applicable
Cefaly® Device in the Treatment of Patients With Fibromyalgia.
NCT02546362
completednot_applicable
Open-trial on the Prevention of Chronic Migraines With the CEFALY Device
NCT02342743
completedphase_1
Acute Treatment of Migraine Using the CEFALY Device
NCT02411513
Clinical Trials (4)
Showing 4 of 4 trials
NCT04838067Not Applicable
Validation of Therapeutic Effects of Cefaly on Insomnia
NCT02546362Not Applicable
Cefaly® Device in the Treatment of Patients With Fibromyalgia.
NCT02342743Not Applicable
Open-trial on the Prevention of Chronic Migraines With the CEFALY Device
NCT02411513Phase 1
Acute Treatment of Migraine Using the CEFALY Device
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4